SonoCine has been an
investigational device since June 2001, which offers new high definition
ultrasound breast cancer detection method that is able to detect breast cancers
that traditional mammogram or conventional ultrasound exams might miss.
SonoCine finally received FDA Approval
in December 2008. SonoCine has also a track record of detecting some cancers
before they can be even felt by breast self examination. The reason why SonoCine stands alone from traditional ultrasound is that it produces from 2,000
to 5,000 permanent images. Traditional ultrasound is only capable of doing 30
Women who have dense breasts
can really benefit from SonoCine as it is harder to see potential visible
cancers on conventional mammography.
Mammograms can miss up to 25 percent of
all breast cancer (according to a recent study) and nearly 50 percent of cancers
in dense breast tissue.
The main difference between
the SonoCine and traditional ultrasound are that ultrasound is not supported by
the American College of Radiology to screen the entire breast. Ultrasound is a
hand held device compared to the SonoCine semi-automatic ability. Ultrasound
also is focused exam only, meaning that they are confirming the diagnosis of
prior mammogram that detected a palpable lump or mass.
Mammograms have saved tens of
thousands of women’s lives each year; however each mammogram consists of only
four static X-ray images, each one taken through the entire thickness of the
breast. As a result, small tumors may be seen within the layers of adjacent
normal breast tissue.
With SonoCine the breast exam captures 2,000 to 5,000
images of thin slices of tissue and links them together so that they may be
viewed like a movie. This makes it easier for the radiologist to see the
disruption in tissue patterns caused by cancer. These anomalies may be obscured
by overlapping tissue in composite mammographic images.
SonoCine currently finds a breast cancer 1 in 2-300 cases that were not
found on the traditional mammogram.
SonoCine does not replace
Mammograms. SonoCine is used to compliment mammograms. SonoCine excels in
finding cancers in dense breast tissue, and has been shown to excel at detecting
these cancers before a lump is felt by self examination. Mammograms can detect
certain other cancers (small calcified non-invasive or minimally invasive
cancers). Mammograms also excel at recognizing cancer in fatty tissue.
The benefits of SonoCine are
noticeable. Women who are at high risk for breast cancer can benefit
substantially from SonoCine. SonoCine is painless; it does not require breast
compression. SonoCine may detect cancers missed by mammograms and may find other
cancers sooner. When combined with mammography, SonoCine may reduce radical and
invasive cancer treatments and increase cancer survival rates because of early
detection. This procedure uses breast ultrasound imaging instead of X-rays.